眼科玻璃体内注射药物的临床应用研究进展  

Progress in clinical application research of intravitreal injection drugs in ophthalmology

作　　者：唐凤敏 黄滔敏 TANG Fengmin;HUANG Taomin(Department of Pharmacy,Eye&ENT Hospital of Fudan University,Shanghai 200031,China)

机构地区：[1]复旦大学附属眼耳鼻喉科医院药剂科,上海200031

出　　处：《中国临床药学杂志》2025年第1期71-76,共6页Chinese Journal of Clinical Pharmacy

基　　金：上海市卫生健康委员会项目(编号202140069)。

摘　　要：玻璃体内注射是眼科常用的给药方法之一,国内外现已有多种药物批准用于玻璃体内注射,如抗血管内皮生长因子、糖皮质激素、补体抑制剂、纤溶酶和抗病毒药物等。通过对目前已获批的玻璃体内注射药物和超说明书用于玻璃体内注射的药物进行综述,为临床玻璃体内注射药物的使用提供参考。Intravitreal injection is one of the commonly used drug administration methods in ophthalmology. There are various drugs approved for intravitreal injection both domestically and internationally, such as anti-vascular endothelial growth factor drugs, glucocorticoids, complement inhibitors, plasmin drugs, and antiviral drugs. This review summarizes the drugs that have been approved and those used off-label for intravitreal injection, providing the reference for the clinical use of intravitreal injection drugs.

关 键 词：玻璃体内注射 血管内皮生长因子 糖皮质激素 玻璃体内植入剂 眼科 

分 类 号：R988[医药卫生—药品]